Article info
Neurodegeneration
Review
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer’s disease: a focused review on recent advances
- Correspondence to Dr Mitchell K.P. Lai, Department of Pharmacology, National University of Singapore, Unit 09-01, 14 Medical Drive, Kent Ridge 117599, Singapore; Mitchell.lai{at}dementia-research.org
Citation
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer’s disease: a focused review on recent advances
Publication history
- Received June 13, 2021
- Accepted August 30, 2021
- First published September 11, 2021.
Online issue publication
October 13, 2021
Article Versions
- Previous version (11 September 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.